Ramakanth Swayampakula

Ramakanth Swayampakula has a diverse work experience spanning over two decades. Ramakanth began their career at Epoch Pharmaceuticals, Inc as a Research Scientist in 1997, before moving on to Regeneron Pharmaceuticals, Inc as a Staff Scientist in 1999. At Regeneron Pharmaceuticals, Inc, they served until 2003, gaining valuable experience in the field.

In 2003, they joined Rodman & Renshaw, LLC as an Associate Research Analyst, and later transitioned to First Albany Capital as a Research Associate in 2006. Following this, Ramakanth joined Merrill Lynch as an Associate Analyst in 2007.

Continuing their career growth, they joined DSM Pharmaceutical Products as a Senior Manager of Strategic Business Intelligence in 2009, but their time there was short-lived as they joined Jefferies & Company as a Healthcare Equity Analyst later that same year. During their tenure at Jefferies & Company, they served until 2014 and contributed significantly to the company's success.

Ramakanth'smost recent position is at H.C. Wainwright & Co., LLC, where they hold the role of Managing Director/Senior Equity Analyst since June 2014. With this breadth of experience in the field, Ramakanth Swayampakula has a well-rounded understanding of the pharmaceutical industry and has consistently demonstrated their capabilities in various roles.

Ramakanth Swayampakula has an extensive education history. Ramakanth started their education in 1980 at Baldwin Boys High School in Bengaluru, India, where they completed their secondary education in 1982. From 1982 to 1984, they attended St. Joseph of Cluny Higher Secondary School in Neyveli, India.

Ramakanth then pursued higher education and enrolled at Birla Institute of Technology and Science in Pilani from 1984 to 1988, although the specific degree and field of study are not provided. Following this, from 1988 to 1990, they attended Auburn University and obtained a Master of Science degree in Pharmaceutics.

Continuing their academic journey, Ramakanth Swayampakula pursued a Ph.D. in Pharmacology from the University of Utah, where they studied from 1990 to 1995.

Later, they took a break from their formal education and obtained an MBA degree from Rutgers University - Newark from 2001 to 2003. Unfortunately, the field of study for their MBA is not mentioned.

Additionally, Ramakanth Swayampakula has obtained several certifications, including NASD 7, 63, 86, and 87. However, the institution and the specific date of certification are not provided.